Valuation: Danaher Corporation

Capitalization 130B 113B 104B 97.85B 182B 12,384B 185B 1,235B 481B 6,012B 490B 479B 20,908B P/E ratio 2026 *
29.2x
P/E ratio 2027 * 23.7x
Enterprise value 139B 121B 111B 105B 195B 13,240B 198B 1,321B 514B 6,427B 524B 512B 22,355B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 5x
Free-Float
71.13%
Yield 2026 *
0.78%
Yield 2027 * 0.83%
1 day-1.25%
1 week+0.89%
Current month+0.89%
1 month+4.92%
3 months-5.73%
6 months-18.54%
Current year-19.49%
1 week 173.63
Extreme 173.63
188.75
1 month 160.93
Extreme 160.93
188.75
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer 63 01/01/2021
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap.
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
05-15Free

Director

2,379 0.0003%
Change 5d. change 1-year change 3-years change Capi.($)
-1.25%+0.89%-5.98%-22.41% 130B
-1.91%-4.00%+17.64%-9.21% 176B
+0.77%-0.61%-24.24%+37.37% 149B
-0.61%+0.50%-52.44%-4.24% 72.16B
-1.70%-0.59%+10.89%+2.97% 49.5B
+0.55%-0.23%-25.32%-33.79% 44.89B
-2.95%-4.75%+4.04%+42.09% 35.87B
+1.35%+3.74%-9.70%-19.64% 29.42B
+0.89%+2.87%-22.27%-8.72% 28.31B
+1.26%-4.90%-37.90%-51.87% 25.78B
Average -0.36%-0.36%-14.53%-6.75% 74.16B
Weighted average by Cap. -0.67%-0.89%-10.02%-1.73%

Financials

2026 *2027 *
Net sales 25.5B 22.14B 20.31B 19.13B 35.57B 2,421B 36.24B 241B 93.97B 1,175B 95.74B 93.65B 4,087B 27.06B 23.49B 21.55B 20.3B 37.74B 2,569B 38.45B 256B 99.7B 1,247B 102B 99.37B 4,337B
Net income 4.54B 3.94B 3.61B 3.4B 6.33B 431B 6.45B 42.96B 16.72B 209B 17.03B 16.66B 727B 5.64B 4.9B 4.49B 4.23B 7.87B 536B 8.02B 53.43B 20.79B 260B 21.18B 20.72B 904B
Net Debt 9.02B 7.83B 7.19B 6.77B 12.59B 857B 12.82B 85.46B 33.25B 416B 33.88B 33.14B 1,446B 4.92B 4.28B 3.92B 3.69B 6.87B 468B 7B 46.64B 18.15B 227B 18.49B 18.09B 789B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
05/06/26 184.30 $ -1.25% 3,305,510
04/06/26 186.64 $ +4.81% 7,771,426
03/06/26 178.08 $ +1.12% 2,909,797
02/06/26 176.11 $ -2.09% 2,914,086
01/06/26 179.87 $ -1.53% 3,652,710
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
184.30USD
Average target price
244.27USD
Spread / Average Target
+32.54%

Quarterly revenue - Rate of surprise